RecruitingPhase 3NCT06961214
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Sponsor: GlaxoSmithKline
Boise, ID · +56 more sites
4 recruiting copd studies with a site in Boise, ID.
Sponsor: GlaxoSmithKline
Boise, ID · +56 more sites
Sponsor: AstraZeneca
Boise, ID · +234 more sites
Sponsor: GlaxoSmithKline
Boise, ID · +41 more sites
Sponsor: Seattle Institute for Biomedical and Clinical Research
Boise, ID · +4 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.